These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18860176)

  • 1. Pentaquine (SN-13,276) a therapeutic agent effective in reducing the relapse rate in vivax malaria.
    ALVING AS; CRAIGE B
    J Clin Invest; 1948 May; 27(3 Pt1):25-33. PubMed ID: 18860176
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentaquine (SN-13,276) a new antimalarial effective in reducing the relapse rate of vivax malaria.
    PULLMAN TN; ALVING AS
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():83. PubMed ID: 20343588
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of pentaquine as a cure of relapsing vivax malaria; a controlled study of 95 cases.
    STRAUS B; GENNIS J
    Bull N Y Acad Med; 1948 Jun; 24(6):395. PubMed ID: 18860470
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of a new antimalarial agent, pentaquine (SN 13,276).
    LOEB RF
    J Am Med Assoc; 1946 Oct; 132():321-3. PubMed ID: 20997215
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria.
    ALVING AS
    Abstr Int Congr Trop Med Malar; 1948; 56(4th Congr):58. PubMed ID: 18872928
    [No Abstract]   [Full Text] [Related]  

  • 6. The toxicity of large doses of pentaquine (SN-13,276) a new antimalarial drug.
    CRAIGE B; EICHELBERGER L
    J Clin Invest; 1948 May; 27(3 Pt1):17-24. PubMed ID: 18860175
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined quinine-plasmochin treatment of vivax malaria; effect of relapse rate.
    MOST H; KANE CA
    Am J Med Sci; 1946 Nov; 212(5):550-60. PubMed ID: 20273918
    [No Abstract]   [Full Text] [Related]  

  • 8. Radical cure of relapsing vivax malaria with pentaquine-quinine; a controlled study.
    STRAUS B; GENNIS J
    Ann Intern Med; 1950 Dec; 33(6):1413-22. PubMed ID: 14790523
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined quinine-plasmochin and quinine-pentaquine treatment of relapsing vivax malaria.
    SPICKNALL CG; TERRY LL
    South Med J; 1948 Apr; 41(4):338-41. PubMed ID: 18905562
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies in human malaria. XXVII. Observations on the use of pentaquine in the prevention and treatment of Chesson strain vivax malaria.
    COATNEY GR; COOPER WC; EYLES DE; CULWELL WB; WHITE WC; LINTS HA
    J Natl Malar Soc; 1950 Sep; 9(3):222-33. PubMed ID: 14795202
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentaquine and quinine in the treatment of Korean vivax malaria; a controlled study in 101 patients.
    HALL WH; LATTS EM
    J Lab Clin Med; 1955 Apr; 45(4):573-9. PubMed ID: 14368020
    [No Abstract]   [Full Text] [Related]  

  • 12. Cure of chronic vivax malaria with pentaquine.
    COGGESHALL LT; RICE FA
    J Am Med Assoc; 1949 Feb; 139(7):437-9. PubMed ID: 18123173
    [No Abstract]   [Full Text] [Related]  

  • 13. Cure of chronic vivax malaria with pentaquine and status of immunity thereafter.
    COGGESHALL LT
    Proc Inst Med Chic; 1949 Jun; 17(15):357. PubMed ID: 18152607
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies in human malaria; the cure of St. Elizabeth strain vivax malaria by pentaquine-quinine, administered during acute attacks or during latency.
    WHITE WC; COOPER WC
    J Natl Malar Soc; 1948 Dec; 7(4):316-21. PubMed ID: 18109266
    [No Abstract]   [Full Text] [Related]  

  • 15. Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report.
    EDGCOMB JH; ARNOLD J; YOUNT EH; ALVING AS; EICHELBERGER L; JEFFERY GM; EYLES D; YOUNG MD
    J Natl Malar Soc; 1950 Dec; 9(4):285-92. PubMed ID: 14804087
    [No Abstract]   [Full Text] [Related]  

  • 16. Pamaquin; suppressive antimalarial activity in vivax and falciparum malaria.
    TAGGART JV; BERLINER RW
    Fed Proc; 1946; 5(1 Pt 2):207. PubMed ID: 20983216
    [No Abstract]   [Full Text] [Related]  

  • 17. The synthesis of 7-chloro-4-(l-ethyl-4-piperidylamino)-quinoline (SN-13,425).
    FUSON RC; PARHAM WE; REED LJ
    J Am Chem Soc; 1946 Jul; 68():1239. PubMed ID: 20990959
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies in human malaria; the therapeutic action of pamaquine against St. Elizabeth strain vivax malaria.
    RUHE DS; COOPER WC
    Am J Hyg; 1949 May; 49(3):367-73. PubMed ID: 18121216
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactions observed during treatment with pentaquine, administered with quinacrine (atabrine) metachloridine (SN-11,437) and with sulfadiazine.
    ATCHLEY JA; YOUNT EH
    J Natl Malar Soc; 1948 Jun; 7(2):118-24. PubMed ID: 18867814
    [No Abstract]   [Full Text] [Related]  

  • 20. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
    Kitchener S; Nasveld P; Edstein MD
    Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.